American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (986)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1255)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (62)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5172)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Safety and efficacy in pediatric patients with relapsed/refractory classic Hodgkin lymphoma enrolled on an intergroup randomized phase II study of the combinations of ipilimumab, nivolumab and brentuximab vedotin (E4412)
    Meeting Abstract

    Forlenza, C. J.; Jegede, O.; Ansell, S. M.; Steidl, C.; Natkunam, Y.; Scott, D. W.; Mehta-Shah, N.; Amengual, J. E.; Cole, P. D.; Kahl, B. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Improved outcomes for primary refractory classical Hodgkin Lymphoma: A retrospective analysis
    Meeting Abstract

    Santarosa, A. M.; Ganesan, N.; Chang, T.; Hannigan, K.; Casper, E.; Shah, G. L.; Boardman, A. P.; Caron, P.; David, K. A.; Dogan, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics, pharmacodynamics and clinical activity of KT-333, a targeted protein degrader of STAT3, in patients with relapsed or refractory lymphomas, leukemia, and solid tumors
    Meeting Abstract

    Feldman, T.; Marchi, E.; Smith, S. D.; Olszewski, A. J.; Huen, A. O.; Epstein-Peterson, Z. D.; Stevens, D. A.; Starodub, A. N.; Feldman, E. J.; Rodriguez, C. P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Addition of blinatumomab to consolidation therapy among older newly diagnosed patients (pts) with BCR::ABL1 negative B-lineage acute lymphoblastic leukemia (ALL) in the ECOG-ACRIN E1910 randomized phase III trial
    Meeting Abstract

    Podoltsev, N. A.; Sun, Z.; Litzow, M. R.; Paietta, E.; Roberts, K. G.; Zhang, Y.; Racevskis, J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Transient inflammatory signals drive persistent changes in the PU.1 transcriptional state of HSC
    Meeting Abstract

    Wheat, J. C.; Steidl, U.
    Blood (2024)

    Fulltext@MSK | Save
  • Mosaic chromosomal alterations driving clonal hematopoiesis show shared and divergent patterns of accumulation among humans of diverse ancestries
    Meeting Abstract

    Kang, J. R. W.; Kim, J.; Skead, K.; Bruat, V.; Harwood, M.; Soave, D.; Morris, Q. D.; Fave, M. J.; Awadalla, P.
    Blood (2024)

    Fulltext@MSK | Save
  • NGS MRD negativity on day 28 after brexu cel in adults with R/R ALL is associated with favorable progression free survival
    Meeting Abstract

    Valtis, Y. K.; Nemirovsky, D.; Devlin, S. M.; Roloff, G. W.; Aldoss, I.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Advani, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Retrospective cohort analysis of response and survival of children, adolescents, and young adults (CAYA) with relapsed and/or refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL) and lymphoma (T-LL) treated with curative intent: A TACL consortium study
    Meeting Abstract

    Pauly, M. G.; Chi, Y. Y.; Malvar, J.; Leong, R.; Colace, S.; Gossai, N.; Hijiya, N.; Parekh, C.; Rheingold, S. R.; Verma, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Uncovering the HOXA9 translational regulatory complex that promotes AML leukemic stem cells
    Meeting Abstract

    Xie, X.; Chavez, F. H.; Baali, I.; Chu, E. L.; Evans, C.; Yang, X.; Wei, W.; Luo, H.; Park, S. M.; Chang, K.; more...
    Blood (2024)

    Fulltext@MSK | Save